Merck has delayed its filing plans for its investigational fixed-dose anti-cholesterol combo (simvastatin plus somthing with a patent) .
It will not file a worldwide marketing application in 2007 as originally suggested.
Things must be shaky...... they've not revealed the new filing date.
More
No comments:
Post a Comment